A detailed history of Schonfeld Strategic Advisors LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 4,477 shares of EXAS stock, worth $256,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,477
Holding current value
$256,890
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $189,959 - $317,105
4,477 New
4,477 $304,000
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $1.06 Million - $1.36 Million
17,967 Added 507.54%
21,507 $1.59 Million
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $336,953 - $506,094
-5,110 Reduced 59.08%
3,540 $241,000
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $542,182 - $822,182
8,650 New
8,650 $812,000
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $144,860 - $253,684
-4,773 Reduced 32.89%
9,740 $482,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $463,980 - $716,506
14,513 New
14,513 $471,000
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $1.38 Million - $1.83 Million
-11,812 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $1.18 Million - $1.68 Million
11,812 New
11,812 $1.57 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $731,533 - $1.02 Million
-10,032 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $1.03 Million - $1.72 Million
-18,525 Reduced 64.87%
10,032 $873,000
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $2.04 Million - $5.62 Million
-53,844 Reduced 65.34%
28,557 $1.66 Million
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $5.66 Million - $7.27 Million
72,926 Added 769.67%
82,401 $7.62 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $856,255 - $1.16 Million
9,475 New
9,475 $856,000
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $1.07 Million - $1.58 Million
-19,100 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $922,339 - $1.54 Million
19,100 New
19,100 $1.51 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.